论文部分内容阅读
目的:分析米索前列醇预防产妇产后出血的临床治疗效果。方法:选择本院足月的妊娠产妇共计100例,采用随机形式分成对照组与实验组,每组产妇50例,其中实验组产妇在胎儿分娩之后应用缩宫素在第一时间内口服米索前列醇500μg,而对照组产妇则在胎儿分娩之后应用缩宫素,并对二组病人在产中以及产后出血量及血压、血红蛋自等数据进行比较。结果:对二组产妇在应用药物前后的血压变化进行对比后,其差异不具有统计学意义,即P>0.05,将二组产妇在分娩后2h内的平均出血量进行对比后,其差异存在统计学意义,即p<0.05,将二组产妇分娩后的血红蛋白进行对比后,其差异存在统计学意义,即p<0.01。结论:综上所述,应用米索前列醇联合缩宫素较之于仅应用缩宫素更加有助于预防产妇出现产后出血,应对其在临床上进行广泛应用。
Objective: To analyze the clinical effect of misoprostol in preventing postpartum hemorrhage. Methods: A total of 100 pregnant women in our hospital were enrolled in this study. They were randomly divided into control group and experimental group, with 50 cases in each group. In the experimental group, the oxytocin was used in the experimental group after oral delivery, PRP was 500μg, while the control group maternal application of oxytocin after fetal delivery, and the two groups of patients in the production and postpartum hemorrhage and blood pressure, hemoglobin since the other data were compared. Results: After comparing the changes of blood pressure before and after the application of drugs, the difference was not statistically significant (P> 0.05). After comparing the mean blood loss of the two groups within 2 hours after delivery, the difference existed Statistical significance, that p <0.05, the two groups of maternal hemoglobin after delivery were compared, the difference was statistically significant, that p <0.01. Conclusion: In summary, the use of misoprostol combined with oxytocin compared with only the application of oxytocin more help prevent maternal postpartum hemorrhage should be widely used in clinical practice.